Cardiovascular disease (CVD) is globally the single most prominent cause of disability and death, accounting for more than 30% of all global deaths. Four out of five CVD deaths are caused by heart attack or cerebral stroke. Main triggers are inactive life style, unhealthy diet, obesity, raised blood pressure or elevated blood glucose levels. Diagnostic screening and simple testing modalities are key in early detection and treatment of CVD.
Founded in 2003, the company (“Company”) is specialized in international sales of cardio- and neurovascular testing devices for practitioners, hospitals and research. It has exclusive distribution contracts from six medical device manufacturers. Export sales are conducted via a long-established distributor network. Services offered include installation, training, and support of studies.
A special relationship exists with the manufacturer (“Manufacturer”) of the company’s core product (“Product”) comprised of a diagnostic device platform covering the complete range from peripheral- to cardio-vascular testing. The Manufacturer is a medically certified company with 14 years of experience in R&D, design and manufacturing.